Shanghai

Takeda gets crafty with molecular glue deal worth $1.2B biobucks

Takeda has taken a trip all the way to Shanghai to find just the right kind of glue to stick together a $1.2 billion biobucks deal for new candidates.

Annalee Armstrong May 23, 2024 5:30am

Rona buys siRNA platform, 4 preclinical liver drugs from Sanofi

Jul 25, 2022 8:41am

Illumina, Sequoia Capital launch genomics incubator in China

Feb 1, 2021 10:22am

Junshi tees up China filing for PD-1 med after throat cancer win

Sep 29, 2020 9:50am

China's Viva Biotech snaps up Hong Kong CRO SYNthesis

Sep 23, 2020 7:40am

AbbVie puts $2B on the table for I-Mab cancer collab

Sep 4, 2020 8:30am